In a tumor-bearing mouse model, CD11b+Ly6G+ cells (i.e. myeloid-derived suppressor cells) express high tumoricidal activity in response to TLR3 agonist by production of reactive oxygen species (ROS) [34]. This evidence concerns the gene ITGAM and neoplasm.